A laboratory evaluation of medicinal herbs used in China for the treatment of hand, foot, and mouth disease

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Xiaoqing ^a   Wang, Chunyang ^a   Xu, Lanfang ^a   Chen, Xiaoshuang ^a,b   Wang, Wei ^a   Yang, Guang ^c   Tan, Ren Xiang ^a   Li, Erguang ^a   Jin, Yu ^a,c  

^a NANJING UNIVERSITY   (China)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACACETIN; ANEMARRHENA ASPHODELOIDES EXTRACT; ARCTIUM LAPPA EXTRACT; CHRYSOSPLENETIN; EUPATORIUM FORTUNEI EXTRACT; FLAVONOID; FORSYTHIA SUSPENSA EXTRACT; GARDENIA JASMINOIDES EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HOUTTUYNIA CORDATA EXTRACT; HYPERIN; I KAPPA B ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; ISATIS INDIGOTICA EXTRACT; ISOQUERCITRIN; KAEMPFEROL; LINARIN; LONICERA JAPONICA EXTRACT; MENTHA HAPLOCALYX EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; QUERCITRIN; SCUTELLARIA BAICALENSIS EXTRACT; TILIANIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANEMARRHENA ASPHODELOIDES; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARCTIUM LAPPA; ARTICLE; CELL VIABILITY; CHINESE HERB; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; DRUG SCREENING; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; EUPATORIUM FORTUNEI; FORSYTHIA SUSPENSA; GARDENIA JASMINOIDES; GLYCYRRHIZA URALENSIS; HAND FOOT AND MOUTH DISEASE; HOUTTUYNIA CORDATA; HUMAN; IC 50; ISATIS INDIGOTICA; LONICERA JAPONICA; MENTHA HAPLOCALYX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCUTELLARIA BAICALENSIS; TRADITIONAL MEDICINE; VIRUS ATTACHMENT; VIRUS INHIBITION;

EID: 84876514233     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/504563     Document Type: Article

References (26)

1. Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., He Y., Bu G., Zhou S., Wang J., Qi J., Enterovirus 71 outbreak in the People's Republic of China in 2008. Journal of Clinical Microbiology 2009 47 7 2351 2352 2-s2.0-67650047737 10.1128/JCM.00563-09
2. WHO,. Report on the Hand, Foot and Mouth Disease Outbreak in Fuyang City, Anhui Province and the Prevention and Control in China. 2008, http://www2.wpro.who.int/NR/rdonlyres/591D6A7B-FB15-4E94-A1E9-1D3381847D60/0/ HFMDCCDC20080515ENG.pdf.
3. Tian H., Yang Q. Z., Liang J., Clinical features and management outcomes of severe hand, foot and mouth disease. Medical Principles and Practice 2012 21 4 355 359 10.1159/000334619
4. Ooi M. H., Wong S. C., Lewthwaite P., Cardosa M. J., Solomon T., Clinical features, diagnosis, and management of enterovirus 71. The Lancet Neurology 2010 9 11 1097 1105 2-s2.0-77957953975 10.1016/S1474-4422(10)70209-X
5. Ma E., Fung C., Yip S. H. L., Wong C., Chuang S. K., Tsang T., Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks. The Pediatric Infectious Disease Journal 2011 30 8 675 679 2-s2.0-79960642626 10.1097/INF.0b013e3182116e95
6. Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H., Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet Infectious Diseases 2010 10 11 778 790 2-s2.0-78049398279 10.1016/S1473-3099(10)70194-8
7. Cao H. J., Liu Z. L., Steinmann P., Chinese herbal medicines for treatment of hand, foot and mouth disease: a systematic review of randomized clinical trials. European Journal of Integrative Medicine 2012 4 1 e85 e111 10.1016/j.eujim.2011.11.004
8. Zhang G. L., Li Z. G., Tong J. B., A review of Chinese traditional prescriptions used in treatment and prevention of hand, foot and mouth disease. Clinical Journal of Traditional Chinese Medicine 2010 22 7 574 582
9. Xue B., Yao Z., Yu R., Studies on anti-EV71 virus activity of traditional Chinese medicine and its clinical application in treatment of HFMD. Zhongguo Zhong Yao Za Zhi 2011 36 23 3366 3370
10. Hozumi T., Matsumoto T., Ooyama H., Antiviral agent containing crude drug. U.S. Patent 5,411,733, 1995
11. Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., Mao N., Xu S., Zhu S., Cui A., Zhang Y., Yan D., Li Q., Dong X., Zhang J., Zhao Y., Wan J., Feng Z., Sun J., Wang S., Li D., Xu W., An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virology Journal 2010 7 1, article 94 2-s2.0-77951991686 10.1186/1743-422X-7-94
12. Reed L. J., Muench H., A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 1938 27 3 493 497 2-s2.0-33745158157
13. Liu C. C., Chou A. H., Lien S. P., Lin H. Y., Liu S. J., Chang J. Y., Guo M. S., Chow Y. H., Yang W. S., Chang K. H. W., Sia C., Chong P., Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine 2011 29 26 4362 4372 2-s2.0-79957836497 10.1016/j.vaccine.2011.04.010
14. Dulbecco R., Vogt M., Plaque formation and isolation of pure lines with poliomyelitis viruses. Journal of Experimental Medicine 1954 99 2 167 182 10.1084/jem.99.2.167
15. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983 65 1-2 55 63 2-s2.0-0021061819 (Pubitemid 14203433)
16. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
17. Lin C. W., Tsai F. J., Tsai C. H., Lai C. C., Wan L., Ho T. Y., Hsieh C. C., Chao P. D. L., Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Research 2005 68 1 36 42 2-s2.0-25144432483 10.1016/j.antiviral.2005.07.002 (Pubitemid 41338580)
18. Ma S. C., Du J., But P. P. H., Deng X. L., Zhang Y. W., Ooi V. E. C., Xu H. X., Lee S. H. S., Lee S. F., Antiviral Chinese medicinal herbs against respiratory syncytial virus. Journal of Ethnopharmacology 2002 79 2 205 211 2-s2.0-0036166889 10.1016/S0378-8741(01)00389-0 (Pubitemid 34136952)
19. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. W., Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet 2003 361 9374 2045 2046 2-s2.0-0038047657 10.1016/S0140-6736(03)13615-X (Pubitemid 36695048)
20. Chang S. J., Chang Y. C., Lu K. Z., Antiviral activity of Isatis indigotica extract and its derived indirubin against Japanese encephalitis virus. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 925830 10.1155/2012/925830
21. Lin T. Y., Liu Y. C., Jheng J. R., Tsai H. P., Jan J. T., Wong W. R., Horng J. T., Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. The American Journal of Chinese Medicine 2009 37 1 143 158 2-s2.0-65449181979
22. Kuo K. K., Chang J. S., Wang K. C., Chiang L. C., Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line. The American Journal of Chinese Medicine 2009 37 2 383 394 2-s2.0-65449126973 10.1142/S0192415X09006904
23. Tsai F. J., Lin C. W., Lai C. C., Lan Y. C., Lai C. H., Hung C. H., Hsueh K. C., Lin T. H., Chang H. C., Wan L., Sheu J. J. C., Lin Y. J., Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chemistry 2011 128 2 312 322 2-s2.0-79955598844 10.1016/j.foodchem.2011.03.022
24. Zhu Q. C., Wang Y., Liu Y. P., Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. European Journal of Pharmaceutical Sciences 2011 44 3 392 398 10.1016/j.ejps.2011.08.030
25. Chen X., Wang Z., Yang Z., Houttuynia cordata blocks HSV infection through inhibition of NF-kappaB activation. Antiviral Research 2011 92 2 341 345 10.1016/j.antiviral.2011.09.005
26. Lin T. Y., Hsia S. H., Huang Y. C., Wu C. T., Chang L. Y., Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clinical Infectious Diseases 2003 36 3 269 274 2-s2.0-0037310094 10.1086/345905 (Pubitemid 36169660)